Early sevoflurane sedation in severe COVID-19-related lung injury patients. A pilot randomized controlled trial
Description
CONCLUSIONS: No evident benefits were observed with short sevoflurane sedation on mortality and POD. Unexpectedly low blood levels of IL-6 might indicate a moderate injury with therefore limited improvement options of sevoflurane. Acute renal issues
